Amgen, US0311621009

Amgen stock pre-market at EUR 386.78

Published on 10/16/2026 at 08:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock is at EUR 386.78 pre-market, according to Lang & Schwarz. The quote was recorded at 8:04 a.m. CEST on October 16, 2026.

Valuation and range

  • The 52-week range was EUR 247.65 to EUR 392.85 on October 15, 2026.
  • Amgen stock traded at EUR 386.78 at 8:04 a.m. CEST on October 16, 2026, according to Lang & Schwarz.
  • Amgen's P/E ratio was 28.47 as of October 15, 2026.
Amgen Inc. (ISIN US0311621009) inspirierte diese dokumentarische Schwarzweiß-Aufnahme einer Forscherin im Biotech-Labor, Illustration mit AI erstellt.

Amgen stock was at EUR 386.78 in pre-market trading at Lang & Schwarz at 8:04 a.m. CEST on October 16, 2026.

Pre-market price

MarketWatch identified Amgen's primary listing as Nasdaq under the ticker AMGN. Its Germany Xetra listing showed a 52-week range of EUR 247.65 to EUR 392.85 and a market capitalization of EUR 207.14 billion as of October 15, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Amgen stock.

What matters today

October 16, 2026 is the current trading date for the pre-market report. MarketWatch lists Amgen's 52-week high at EUR 392.85, which is EUR 6.07 above the Lang & Schwarz price. MarketWatch reports a price-earnings ratio of 28.47 as of October 15, 2026. MarketWatch provided the listed Xetra figures.

Market context: Market report Nasdaq Composite.

More news and analysis on Amgen stock

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70336316 | bgmi